Biotech

All Articles

Angelini pens $360M biobucks deal for ph. 1 brain problem medication

.Italy's Angelini Pharma has actually authorized a $360 thousand biobucks pact fixated a phase 1-sta...

Sage lays off half of R&ampD staff and shocks C-suite again

.Sage Therapeutics' most recent try to shrink its own pipeline as well as staff will observe a 3rd o...

With period 1 record, Atmosphere possesses an eye on early-stage bladder cancer cells

.Along with its own lead candidate in a period 3 test for a rare eye cancer cells, Mood Biosciences ...

Less than a year in, BenevolentAI CEO is actually out-- Chutes &amp Ladders

.Accept to recently's Chutes &amp Ladders, our roundup of substantial management hirings, shootings ...

Roche MAGE-A4 trial withdrawn after important testimonial

.Roche has actually created another MAGE-A4 course fade away, withdrawing a stage 1 trial of a T-cel...

FDA places predisposed hold on BioNTech-OncoC4 stage 3 trial

.The FDA has carried out a predisposed hang on a phase 3 non-small mobile lung cancer cells practice...

REGiMMUNE, Kiji merge to generate Treg 'incredibly provider,' strategy IPO

.Taiwan's REGiMMUNE and Europe-based Kiji Rehabs are combining to create an internationally minded g...

With trial gain, Merck tries to tackle Sanofi, AZ in RSV

.3 months after showing that its own breathing syncytial infection (RSV) precautionary antibody cles...

Noema checks off phase 2a Tourette gain for ex-Roche molecule

.Noema Pharma has acquired a phase 2a gain for its Tourette disorder drug applicant, disclosing appe...

Terray puts together $120M collection B to advance AI-powered molecules

.Terray Rehabs has actually raked in $120 thousand for a collection B fundraise as the AI-focused bi...